Stealth BioTherapeutics (MITO) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts MITO Hot Sheet
Join SI Premium – FREE
Stealth BioTherapeutics (NASDAQ: MITO) reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02).
For earnings history and earnings-related data on Stealth BioTherapeutics (MITO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- OceanaGold to acquire Ausgold in a deal valued at A$776M
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
